Endometriosis as an epigenetically regulated disease

Aberrant methylation of the IL‐12B promotor region contributes to the risk of developing ovarian endometriosis


Key Points Lay Summary

Consquences of endometriosis in menopausal period.

Around 2-4% of endometriotic women are estimated to suffer from endometriosis after menopause.


Key Points Lay Summary

Is there any difference between endometriosis patients with or without obliterated cul-de-sac during laparoscopic hysterectomy?

Patients with stage IV endometriosis and obliterated cul-de-sac should be managed by the surgeons experienced in minimally invasive gynecologic operations due to the difficulty of the surgery and the necessity of additional procedures.


Key Points Lay Summary

A new technique for laparoscopic management of ovarian endometriosis.

"Surgicel"-treated endometriomas during laparoscopy show low recurrence rate.


Key Points Lay Summary

Which surgical approach for bowel endometriosis?

An endometriotic bowel nodule with similar characteristics may be managed by different strategies following a “patient-oriented treatment”.


Key Points Lay Summary

Immunotherapy for endometrisosis: Will it be possible?

Evidences point to modifications on Natural Killer (NK) cells of the immune system could have a potential therapeutic role in endometriosis


Key Points Lay Summary

Perinatal risk factors for endometriosis

The exposure to an adverse environment or restricted development during the perinatal period may increase the risk of endometriosis.


Key Points Lay Summary
‹ First  < 161162 163 >  Last ›